12/07/2023
How is the medcomms landscape evolving? Given the sheer number of drugs in the pipeline, the industry is poised for growth, said our expert. Read more critical insights from their recent Forum interview. 👇
Our expert told Third Bridge Forum that the market is highly exposed to labour challenges, and they expect "real demand from pharma" on players to move from manpower-driven to more automated support.
This latest industry insights piece highlights what multiple experts have told Third Bridge Forum regarding industry demand, partnership opportunities and how companies evolve.
Read the full piece here: https://bit.ly/44Ia1GM
Forum Industry Insights How is the medcomms landscape evolving? Private Equity Healthcare Europe Published: July 2023 The pharmaceutical industry has become incredibly competitive, with the number of companies with active R&D pipelines increasing from 1,198 in 2001 to over 5,500 in 2023*. Companies....